Welcome to our dedicated page for Jupiter Wellness news (Ticker: jupw), a resource for investors and traders seeking the latest updates and insights on Jupiter Wellness stock.
Jupiter Wellness, Inc. (JUPW) drives innovation in CBD-infused therapeutic products, from sun care lotions to advanced dermatological solutions. This page serves as the definitive source for verified company updates, offering stakeholders timely access to official announcements.
Find curated press releases covering new product launches across Canisun, Caniskin, and CanidermRx brands, regulatory milestones in the CBD sector, financial disclosures, and strategic partnerships. Each update is sourced directly from Jupiter Wellness to ensure accuracy and compliance with financial reporting standards.
Investors and industry observers can use this resource to monitor JUPW's growth in the competitive wellness market. Bookmark this page for efficient tracking of the company's advancements in CBD research and consumer product development.
Jupiter Wellness (JUPW) announced the closing of a registered direct offering and a concurrent private placement, raising approximately $4.1 million. The company sold 4,315,787 shares and issued 8,631,574 warrants to purchase common stock at $1.00 per share. The purchase price for one share and the two warrants was $0.95. The warrants have a term of 3 and 5 years from the initial exercise date. Aegis Capital Corp. acted as the exclusive placement agent. This offering was made under an effective shelf registration statement with the SEC, and the securities are restricted to accredited investors.
Jupiter Wellness Inc (Nasdaq:JUPW) has announced that shareholders of record as of December 30, 2022, can claim a digital coupon NFT worth $179 for a package of its CBD-infused products. Shareholders can trade this NFT globally on the Upstream trading app or redeem it for products including Comfort Cream, CaniSun sunscreens, and lip balms. This initiative, launched following the company's listing on Upstream on January 10, 2023, aims to engage shareholders and attract new customers. The digital coupons are issued as ERC-721 tokens and are limited to one per shareholder, with a verification process in place.
Jupiter Wellness, Inc. (JUPW) announced on January 19, 2023, a definitive agreement for a registered direct offering of 4,315,786 shares and a concurrent private placement of 8,631,572 warrants. The shares are priced at $0.95, with an expected gross proceeds of $4.1 million. The warrants are structured with varying terms: 3 years and 5 years from the initial exercise date. The transactions are anticipated to close around January 23, 2022, pending customary conditions. Aegis Capital Corp. acts as the Exclusive Placement Agent, with the offering made under an effective shelf registration statement. Investors are advised to review the prospectus supplement for details.
Jupiter Wellness, Inc. (Nasdaq:JUPW) shared its 2023 outlook highlighting significant achievements in 2022. Noteworthy developments include dual-listing on the Upstream trading app, a confidential SEC registration for its SRM Entertainment division, and successful product launches like Photocil in India. The company reported record revenues for 2022, with successful sales of its NoStingz sunscreen. A licensing agreement with Taisho Pharmaceutical for the Japanese market and new product developments enhance growth prospects. Jupiter Wellness remains committed to increasing shareholder value and profitability in 2023.
Jupiter Wellness Inc. (Nasdaq: JUPW) has announced its dual listing on Upstream, starting January 10, 2023, at 10:00 am EST. This trading app for digital securities allows global investors to trade JUPW shares. The company aims to provide enhanced accessibility to a wider investor base, showcasing its commitment to growth in hair, skin, and sexual wellness. The Upstream platform features real-time trading and a transparent order book. However, U.S. investors can only liquidate existing securities.
Jupiter Wellness (NASDAQ:JUPW) has announced its initiative to reward shareholders of record with a digital coupon valued at $179, redeemable for an assortment of CBD-infused wellness products. This strategy aims to enhance shareholder engagement and drive potential revenue. Shareholders as of December 30, 2022, will qualify for this offer, with coupons issued on January 23, 2023. Additionally, the company is preparing for its listing on Upstream, set for January 10, 2023, which will facilitate trading and engagement for shareholders.
Jupiter Wellness (Nasdaq:JUPW) announced a spin-off of SRM Entertainment, which has filed a registration statement with the SEC to separate from Jupiter Wellness. SRM will become an independent public company, with Jupiter remaining the majority shareholder. This spin-off aims to provide capital for SRM's growth while distributing shares to Jupiter's shareholders. However, Jupiter Wellness has also delayed the second half of its head-to-head trial for JW-100 pending an FDA meeting.
Jupiter Wellness has announced its approval for a dual listing on Upstream, starting January 10, 2023, under the ticker JUPW. This innovative trading platform enables global investors to trade using various payment methods, enhancing liquidity and price discovery. On listing day, shareholders will receive a commemorative NFT. CEO Brian John emphasized the goal of expanding shareholder value and reaching a broader investor base. The Upstream platform offers a regulated marketplace for digital securities and NFTs, promoting transparent trading.
Jupiter Wellness (NASDAQ:JUPW) announced significant corporate updates in its latest shareholder letter. The company restarted clinical trials for tinnitus and eczema, expanded its market into Female Sexual Wellness, and received FDA approval for its psoriasis and vitiligo treatment in India. Notably, revenues surged 228% to $1.57 million for Q3 2022 and 398% to $5.29 million for the first nine months compared to 2021. Highlights include exclusive licensing agreements and a dual listing plan on Upstream, enhancing liquidity and investor access.
